CONNECT WITH US
eCommerce

eCommerce

Ultraviolette Launches X-47 Venom Electric Motorcycle at 265,000 Rupees

Retail News Asia logo

Published on

Add as a preferred source on Google
Ultraviolette Launches X-47 Venom Electric Motorcycle at 265,000 Rupees

Bengaluru startup Ultraviolette Automotive launched the X-47 Venom electric crossover motorcycle in India with an introductory starting price of 265,000 rupees. The model debuts the manufacturer’s proprietary 100-volt VX-100 powertrain architecture, built around an 11-kilowatt-hour battery pack.

Standard retail pricing starts at 300,000 rupees, but the company cut 35,000 rupees off the sticker for the first 5,000 buyers to spur initial volumes. Co-founder Niraj Rajmohan confirmed European deliveries will commence in early 2027 following the motorcycle’s regional premiere on 3 November 2026.

The VX-100 setup combines the SRB-11 battery pack with an aviation-derived motor dubbed Light Fury and an in-house motor controller. Ultraviolette states the SRB-11 pack offers 25 per cent higher energy density, cools twice as fast, weighs 15 per cent less, and charges twice as quickly as the SRB10 battery on earlier builds. It supports direct-current charging at rates up to 12 kW.

Weighing 2.5 kg, the motor controller employs silicon carbide power transistors, cutting mass by 40 per cent while tripling power density over the previous unit. The motor uses soft magnetic composites and a trapezoidal coil topology, spinning up to 9,000 rpm. A standard 30 kW motor configuration pushes the motorcycle from zero to 100 kph in 5.9 seconds, reaching a top speed of 155 kph.

Buyers can choose across four trims: standard, plus, Recon, and Recon+. 5 kWh battery providing an Indian Driving Cycle range of 227 kilometres. The Recon and Recon+ variants step up to the 11 kWh pack, extending IDC range to 343 kilometres.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.